首页> 美国卫生研究院文献>Biomolecules >FMSP-Nanoparticles Induced Cell Death on Human Breast Adenocarcinoma Cell Line (MCF-7 Cells): Morphometric Analysis
【2h】

FMSP-Nanoparticles Induced Cell Death on Human Breast Adenocarcinoma Cell Line (MCF-7 Cells): Morphometric Analysis

机译:FMSP-纳米颗粒诱导人乳腺癌细胞系(MCF-7细胞)的细胞死亡:形态分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Currently, breast cancer treatment mostly revolves around radiation therapy and surgical interventions, but often these treatments do not provide satisfactory relief to the patients and cause unmanageable side-effects. Nanomaterials show promising results in treating cancer cells and have many advantages such as high biocompatibility, bioavailability and effective therapeutic capabilities. Interestingly, fluorescent magnetic nanoparticles have been used in many biological and diagnostic applications, but there is no report of use of fluorescent magnetic submicronic polymer nanoparticles (FMSP-nanoparticles) in the treatment of human breast cancer cells. In the present study, we tested the effect of FMSP-nanoparticles on human breast cancer cells (MCF-7). We tested different concentrations (1.25, 12.5 and 50 µg/mL) of FMSP-nanoparticles in MCF-7 cells and evaluated the nanoparticles response morphometrically. Our results revealed that FMSP-nanoparticles produced a concentration dependent effect on the cancer cells, a dose of 1.25 µg/mL produced no significant effect on the cancer cell morphology and cell death, whereas dosages of 12.5 and 50 µg/mL resulted in significant nuclear augmentation, disintegration, chromatic condensation followed by dose dependent cell death. Our results demonstrate that FMSP-nanoparticles induce cell death in MCF-7 cells and may be a potential anti-cancer agent for breast cancer treatment.
机译:当前,乳腺癌的治疗主要围绕放射治疗和外科手术,但是这些治疗常常不能为患者提供令人满意的缓解并引起难以控制的副作用。纳米材料在治疗癌细胞方面显示出令人鼓舞的结果,并具有许多优势,例如高生物相容性,生物利用度和有效的治疗能力。有趣的是,荧光磁性纳米颗粒已经用于许多生物学和诊断应用中,但是没有报道将荧光磁性亚微米聚合物纳米颗粒(FMSP-纳米颗粒)用于治疗人乳腺癌细胞。在本研究中,我们测试了FMSP纳米颗粒对人乳腺癌细胞(MCF-7)的作用。我们在MCF-7细胞中测试了不同浓度(1.25、12.5和50 µg / mL)的FMSP-纳米颗粒,并通过形态计量学评估了纳米颗粒的响应。我们的结果表明,FMSP纳米颗粒对癌细胞产生浓度依赖性的影响,1.25 µg / mL的剂量对癌细胞的形态和细胞死亡无明显影响,而12.5和50 µg / mL的剂量却对癌细胞产生显着影响。扩增,崩解,色团凝结,然后是剂量依赖性细胞死亡。我们的结果表明,FMSP纳米颗粒可诱导MCF-7细胞死亡,并且可能是乳腺癌治疗的潜在抗癌药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号